Author Archives: davidrcurry

COVID-19 vaccine passport for safe resumption of travel

Posted on by

Journal of Travel Medicine
Volume 28, Issue 4, May 2021
https://academic.oup.com/jtm/issue

 

Editorial
COVID-19 vaccine passport for safe resumption of travel
Androula Pavli, MD, FRACGP, DTM, PhD, FISTM, Helena C Maltezou, MD, PhD, DU
Journal of Travel Medicine, Volume 28, Issue 4, May 2021, taab079, https://doi.org/10.1093/jtm/taab079
The spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues despite the implementation of effective restrictive public health measures, including strict travel restrictions. In light of safe and effective vaccines against COVID-19, ‘vaccine passports’, as a temporary recommendation will facilitate resumption of travel.

What can we learn from COVID-19 vaccine R&D in China? A discussion from a public policy perspective

Posted on by

Journal of Travel Medicine
Volume 28, Issue 4, May 2021
https://academic.oup.com/jtm/issue

 

Perspectives
What can we learn from COVID-19 vaccine R&D in China? A discussion from a public policy perspective
Yinglian Hu, PhD, Simiao Chen, ScD
Journal of Travel Medicine, Volume 28, Issue 4, May 2021, taab026, https://doi.org/10.1093/jtm/taab026
Given China’s relatively weak innovative and regulatory capacity compared with developed countries, China’s progress on COVID-19 vaccines is especially impressive. We summarize three key lessons from China’s experience with COVID-19 vaccine R&D: (i) set strategic vaccine R&D goals and achieve broad consensus; (ii) strengthen coordination across government agencies and (iii) adopt the state-driven collaborative model.

A million-dose success for Nepal: insights from Nepal’s national vaccine deployment plan against COVID-19

Posted on by

Journal of Travel Medicine
Volume 28, Issue 4, May 2021
https://academic.oup.com/jtm/issue

 

A million-dose success for Nepal: insights from Nepal’s national vaccine deployment plan against COVID-19
Suraj Bhattarai, MD, Jaya Dhungana, MN
Journal of Travel Medicine, Volume 28, Issue 4, May 2021, taab027, https://doi.org/10.1093/jtm/taab027

Making sound public health decisions for the roll-out of COVID-19 vaccines

Posted on by

Journal of Travel Medicine
Volume 28, Issue 4, May 2021
https://academic.oup.com/jtm/issue

 

Making sound public health decisions for the roll-out of COVID-19 vaccines
Priyanka, PhD, Om Prakash Choudhary,, PhD, Indraj Singh, MD
Journal of Travel Medicine, Volume 28, Issue 4, May 2021, taab031, https://doi.org/10.1093/jtm/taab031
The universal mitigation of the pandemic triggered by severe acute respiratory syndrome coronavirus 2 relies on successfully implementing a fast-paced immunization program based on an efficient framework encompassing the in-field logistics of the vaccine distribution, coverage and efficacy. The forthcoming challenges and resolution plans for executing the coronavirus disease 2019 vaccination have been comprehensively outlined in the present discourse.

What must be done to tackle vaccine hesitancy and barriers to COVID-19 vaccination in migrants?

Posted on by

Journal of Travel Medicine
Volume 28, Issue 4, May 2021
https://academic.oup.com/jtm/issue

 

What must be done to tackle vaccine hesitancy and barriers to COVID-19 vaccination in migrants?
Alison F Crawshaw, MSc, Anna Deal, MSc, Kieran Rustage, MPhil, Alice S Forster, PhD, Ines Campos-Matos, MD, PhD …
Journal of Travel Medicine, Volume 28, Issue 4, May 2021, taab048, https://doi.org/10.1093/jtm/taab048
Migrants have been disproportionately impacted by COVID-19 and emerging evidence suggests they may face barriers to COVID-19 vaccination. Participatory approaches and engagement strategies are urgently needed to strengthen uptake, alongside innovative delivery mechanisms and sharing of best practice, to ensure migrants are better consider within countries’ existing vaccine priority structures.

Inactivated COVID-19 vaccine BBV152/COVAXIN effectively neutralizes recently emerged B.1.1.7 variant of SARS-CoV-2

Posted on by

Journal of Travel Medicine
Volume 28, Issue 4, May 2021
https://academic.oup.com/jtm/issue

 

Inactivated COVID-19 vaccine BBV152/COVAXIN effectively neutralizes recently emerged B.1.1.7 variant of SARS-CoV-2
Gajanan N Sapkal, PhD, Pragya D Yadav, PhD, Raches Ella, MS, Gururaj R Deshpande, PhD, Rima R Sahay, MD …
Journal of Travel Medicine, Volume 28, Issue 4, May 2021, taab051,

Changes in the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis during the COVID-19 pandemic in 26 countries and territories in the Invasive Respiratory Infection Surveillance Initiative: a prospective analysis of surveillance data

Posted on by

Lancet Digital Health
Jun 2021 Volume 3 Number 6 e330-e407
https://www.thelancet.com/journals/landig/issue/current

 

Articles
Changes in the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis during the COVID-19 pandemic in 26 countries and territories in the Invasive Respiratory Infection Surveillance Initiative: a prospective analysis of surveillance data
Angela B Brueggemann, et al

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial

Posted on by

Lancet Infectious Diseases
Jun 2021 Volume 21 Number 6 p743-888, e141-e181
https://www.thelancet.com/journals/laninf/issue/current

 

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial
Zhiwei Wu, et al.

Immunogenicity and safety of a novel ten-valent pneumococcal conjugate vaccine in healthy infants in The Gambia: a phase 3, randomised, double-blind, non-inferiority trial

Posted on by

Lancet Infectious Diseases
Jun 2021 Volume 21 Number 6 p743-888, e141-e181
https://www.thelancet.com/journals/laninf/issue/current

 

Immunogenicity and safety of a novel ten-valent pneumococcal conjugate vaccine in healthy infants in The Gambia: a phase 3, randomised, double-blind, non-inferiority trial
Ed Clarke, et al.
Open Access

Effects of different types of written vaccination information on COVID-19 vaccine hesitancy in the UK (OCEANS-III): a single-blind, parallel-group, randomised controlled trial

Posted on by

Lancet Public Health
Jun 2021 Volume 6 Number 6 e346-e433
https://www.thelancet.com/journals/lanpub/issue/current

 

Articles
Effects of different types of written vaccination information on COVID-19 vaccine hesitancy in the UK (OCEANS-III): a single-blind, parallel-group, randomised controlled trial
Daniel Freeman, et al.

A global public health convention for the 21st century

Posted on by

Lancet Public Health
Jun 2021 Volume 6 Number 6 e346-e433
https://www.thelancet.com/journals/lanpub/issue/current

 

Health Policy
A global public health convention for the 21st century
Johnathan H Duff, et al
Summary
As shown by COVID-19, infectious diseases with a pandemic potential present a grave threat to health and wellbeing. Although the International Health Regulations provide a framework of binding legal obligations for pandemic prevention, preparedness, and response, many countries do not comply with these regulations. There is a need for a renewed framework for global collective action that ensures conformity with international regulations and promotes effective prevention and response to pandemic infectious diseases. This Health Policy identifies the necessary characteristics for a new global public health security convention designed to optimise prevention, preparedness, and response to pandemic infectious diseases. We propose ten recommendations to strengthen global public health governance and promote compliance with global health security regulations. Recommendations for a new global public health security convention include greater authority for a global governing body, an improved ability to respond to pandemics, an objective evaluation system for national core public health capacities, more effective enforcement mechanisms, independent and sustainable funding, representativeness, and investment from multiple sectors, among others. The next steps to achieve these recommendations include assembling an invested alliance, specifying the operational structures of a global public health security system, and overcoming barriers such as insufficient political will, scarcity of resources, and individual national interests.

Will SARS-CoV-2 variants of concern affect the promise of vaccines?

Posted on by

Nature Reviews Immunology
Volume 21 Issue 6, June 2021
https://www.nature.com/nri/volumes/21/issues/6

 

Comment | 29 April 2021
Will SARS-CoV-2 variants of concern affect the promise of vaccines?
This Comment discusses how the emerging SARS-CoV-2 variants of concern could impact on the hopes of long-term pandemic control through vaccination and the mutations that might be relevant to the design of modified vaccines.
Ravindra K. Gupta

Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection

Posted on by

Nature Reviews Immunology
Volume 21 Issue 6, June 2021
https://www.nature.com/nri/volumes/21/issues/6

 

Perspective | 29 April 2021
Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection
The duration of immunity to coronavirus disease 2019 (COVID-19) from prior infection and longer-term risk of reinfection are currently unclear. Cromer and colleagues discuss the immune control of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and the implications of this for the future control of the pandemic.
Deborah Cromer, Jennifer A. Juno, Miles P. Davenport

ENABLE: an engine for European antibacterial drug discovery and development

Posted on by

Nature Reviews Drug Discovery
Volume 20 Issue 6, June 2021
https://www.nature.com/nrd/volumes/20/issues/6

 

Comment | 04 May 2021
ENABLE: an engine for European antibacterial drug discovery and development
ENABLE is an antibacterial drug discovery and development consortium formed as a public–private partnership in 2014 as part of the Innovative Medicines Initiative (IMI) New Drugs for Bad Bugs (ND4BB) programme. With the project soon ending, here we provide a brief overview and reflect on its achievements, strengths and weaknesses.
Marie Olliver, Laura Griestop, Anders Karlén

Emerging concepts in the science of vaccine adjuvants

Posted on by

Nature Reviews Drug Discovery
Volume 20 Issue 6, June 2021
https://www.nature.com/nrd/volumes/20/issues/6

 

Review Article | 06 April 2021
Emerging concepts in the science of vaccine adjuvants
This Review discusses how recent advances in understanding the activation of the innate immune system are shedding light on the immunological mechanisms of action of adjuvants and highlights how systems-based approaches are beginning to revitalize adjuvant design and development.
Bali Pulendran, Prabhu S. Arunachalam, Derek T. O’Hagan

Global economic costs due to vivax malaria and the potential impact of its radical cure: A modelling study

Posted on by

PLoS Medicine
http://www.plosmedicine.org/
(Accessed 5 Jun 2021)

 

Global economic costs due to vivax malaria and the potential impact of its radical cure: A modelling study
Angela Devine, Katherine E. Battle, Niamh Meagher, Rosalind E. Howes, Saber Dini, Peter W. Gething, Julie A. Simpson, Ric N. Price, Yoel Lubell
Research Article | published 01 Jun 2021 PLOS Medicine
https://doi.org/10.1371/journal.pmed.1003614

In science we (should) trust: Expectations and compliance across nine countries during the COVID-19 pandemic

Posted on by

PLoS One
http://www.plosone.org/
[Accessed 5 Jun 2021]

 

In science we (should) trust: Expectations and compliance across nine countries during the COVID-19 pandemic
Cristina Bicchieri, Enrique Fatas, Abraham Aldama, Andrés Casas, Ishwari Deshpande, Mariagiulia Lauro, Cristina Parilli, Max Spohn, Paula Pereira, Ruiling Wen
Research Article | published 04 Jun 2021 PLOS ONE
https://doi.org/10.1371/journal.pone.0252892

Influenza vaccine community outreach: Leveraging an interprofessional healthcare student workforce to immunize marginalized populations

Posted on by

Preventive Medicine
Volume 147 June 2021
https://www.sciencedirect.com/journal/preventive-medicine/vol/147/suppl/C

 

Research article only
Influenza vaccine community outreach: Leveraging an interprofessional healthcare student workforce to immunize marginalized populations
Sarah H. Brown, Emilie L. Fisher, Alexandra Q. Taylor, Kevin E. Neuzil, … Robert F. Miller
Article 106460

Links between conspiracy beliefs, vaccine knowledge, and trust: Anti-vaccine behavior of Serbian adults

Posted on by

Social Science & Medicine
Volume 277 May 2021
https://www.sciencedirect.com/journal/social-science-and-medicine/vol/277/suppl/C

 

Research article Abstract only
Links between conspiracy beliefs, vaccine knowledge, and trust: Anti-vaccine behavior of Serbian adults
J. Milošević Đorđević, S. Mari, M. Vdović, A. Milošević
Article 113930

Global, regional and national disability-adjusted life years due to HIV from 1990 to 2019: findings from the Global Burden of Disease Study 2019

Posted on by

Tropical Medicine & International Health
Volume 26, Issue 6 Pages: i-iv, 609-714 June 2021
https://onlinelibrary.wiley.com/toc/13653156/current

 

Original Research Papers
Global, regional and national disability-adjusted life years due to HIV from 1990 to 2019: findings from the Global Burden of Disease Study 2019
Jiayuan Wu, Tianwen Lai, Huanqin Han, Jie Liu, Shuangmiao Wang, Jun Lyu
Pages: 610-620
First Published: 27 February 2021

Rotavirus disease and health care utilisation among children under 5 years of age in highly developed countries: A systematic review and meta-analysis

Posted on by

Vaccine
Volume 39, Issue 22 Pages 2907-3102 (21 May 2021)
https://www.sciencedirect.com/journal/vaccine/vol/39/issue/22

 

Review article Open access
Rotavirus disease and health care utilisation among children under 5 years of age in highly developed countries: A systematic review and meta-analysis
Cristina Ardura-Garcia, Christian Kreis, Milenko Rakic, Manon Jaboyedoff, … Claudia E. Kuehni
Pages 2917-2928

Effective interventions to increase routine childhood immunization coverage in low socioeconomic status communities in developed countries: A systematic review and critical appraisal of peer-reviewed literature

Posted on by

Vaccine
Volume 39, Issue 22 Pages 2907-3102 (21 May 2021)
https://www.sciencedirect.com/journal/vaccine/vol/39/issue/22

 

Review article Abstract only
Effective interventions to increase routine childhood immunization coverage in low socioeconomic status communities in developed countries: A systematic review and critical appraisal of peer-reviewed literature
Amanda Alberga Machado, Sarah A. Edwards, Melissa Mueller, Vineet Saini
Pages 2938-2964

Within-country age-based prioritisation, global allocation, and public health impact of a vaccine against SARS-CoV-2: A mathematical modelling analysis

Posted on by

Vaccine
Volume 39, Issue 22 Pages 2907-3102 (21 May 2021)
https://www.sciencedirect.com/journal/vaccine/vol/39/issue/22

 

Research article Open access
Within-country age-based prioritisation, global allocation, and public health impact of a vaccine against SARS-CoV-2: A mathematical modelling analysis
Alexandra B. Hogan, Peter Winskill, Oliver J. Watson, Patrick G.T. Walker, … Azra C. Ghani
Pages 2995-3006

Transmission of Vaccination Attitudes and Uptake Based on Social Contagion Theory: A Scoping Review

Posted on by

Vaccines — Open Access Journal
http://www.mdpi.com/journal/vaccines

 

(Accessed 5 Jun 2021)
Open Access Review
Transmission of Vaccination Attitudes and Uptake Based on Social Contagion Theory: A Scoping Review
by Pinelopi Konstantinou et al.
Vaccines 2021, 9(6), 607; https://doi.org/10.3390/vaccines9060607 (registering DOI) – 05 Jun 2021
Abstract
Vaccine hesitancy is a complex health problem, with various factors involved including the influence of an individual’s network. According to the Social Contagion Theory, attitudes and behaviours of an individual can be contagious to others in their social networks. This scoping review aims […]

Knowledge, Attitudes and Practices (KAP) toward the COVID-19 Vaccine in Oman: A Pre-Campaign Cross-Sectional Study

Posted on by

Vaccines — Open Access Journal
http://www.mdpi.com/journal/vaccines

 

Open Access Article
Knowledge, Attitudes and Practices (KAP) toward the COVID-19 Vaccine in Oman: A Pre-Campaign Cross-Sectional Study
by Sabria Al-Marshoudi et al
Vaccines 2021, 9(6), 602; https://doi.org/10.3390/vaccines9060602 (registering DOI) – 04 Jun 2021
Abstract
Oman is globally acknowledged for its well-structured immunization program with high vaccination coverage. The massive spread of misinformation brought on by the COVID-19 pandemic, as well as the easy access to various media channels, may affect acceptance of a vaccine, despite the inherent […]

Lack of Trust, Conspiracy Beliefs, and Social Media Use Predict COVID-19 Vaccine Hesitancy

Posted on by

Vaccines — Open Access Journal
http://www.mdpi.com/journal/vaccines

 

Open Access Article
Lack of Trust, Conspiracy Beliefs, and Social Media Use Predict COVID-19 Vaccine Hesitancy
by Will Jennings et al.
Vaccines 2021, 9(6), 593; https://doi.org/10.3390/vaccines9060593 – 03 Jun 2021
Abstract
As COVID-19 vaccines are rolled out across the world, there are growing concerns about the roles that trust, belief in conspiracy theories, and spread of misinformation through social media play in impacting vaccine hesitancy. We use a nationally representative survey of 1476 adults […]

Challenges and Opportunities of Mass Vaccination Centers in COVID-19 Times: A Rapid Review of Literature

Posted on by

Vaccines — Open Access Journal
http://www.mdpi.com/journal/vaccines

 

Open Access Review
Challenges and Opportunities of Mass Vaccination Centers in COVID-19 Times: A Rapid Review of Literature
by Vincenza Gianfredi et al.
Vaccines 2021, 9(6), 574; https://doi.org/10.3390/vaccines9060574 – 01 Jun 2021
Abstract
A mass vaccination center is a location, normally used for nonhealthcare activities, set up for high-volume and high-speed vaccinations during infectious disease emergencies. The high contagiousness and mortality of COVID-19 and the complete lack of population immunity posed an extraordinary threat for global […]

Media/Policy Watch

Posted on by

Media/Policy Watch
This watch section is intended to alert readers to substantive news, analysis and opinion from the general media and selected think tanks and similar organizations on vaccines, immunization, global public health and related themes. Media Watch is not intended to be exhaustive, but indicative of themes and issues CVEP is actively tracking. This section will grow from an initial base of newspapers, magazines and blog sources, and is segregated from Journal Watch above which scans the peer-reviewed journal ecology.
We acknowledge the Western/Northern bias in this initial selection of titles and invite suggestions for expanded coverage. We are conservative in our outlook in adding news sources which largely report on primary content we are already covering above. Many electronic media sources have tiered, fee-based subscription models for access. We will provide full-text where content is published without restriction, but most publications require registration and some subscription level.
The sheer volume of vaccine and pandemic-related coverage is extraordinary. We will strive to present the most substantive analysis and commentary we encounter.

 

The Atlantic
http://www.theatlantic.com/magazine/
Accessed 5 Jun 2021
[No new, unique, relevant content]

 

BBC
http://www.bbc.co.uk/
Accessed 5 Jun 2021
[No new, unique, relevant content]

 

The Economist
http://www.economist.com/
Accessed 5 Jun 2021
[No new, unique, relevant content]

 

Financial Times
https://www.ft.com/
Accessed 5 Jun 2021
[No new, unique, relevant content]
Top of Form
Bottom of Form

 

Forbes
http://www.forbes.com/
Accessed 5 Jun 2021
Jun 5, 2021, 2021
Royal Caribbean Won’t Require Covid-19 Vaccination To Ride U.S. Cruises
Florida Governor Ron DeSantis recently signed a law that could charge cruise ship operators $5,000 every time they require a person to provide proof of vaccination to board a cruise ship.
By Bruce Y. Lee Senior Contributor

Covid Is Still Surging In These Countries Amid Uneven Vaccine Rollout
Covid cases have tripled in Argentina and octupled in Malaysia over the last two months.
By Joe Walsh Forbes Staff

 

Foreign Affairs
http://www.foreignaffairs.com/
Accessed 5 Jun 2021
Snapshot June 4, 2021
COVID’s Haves and Have-Nots
Vaccinating the world will be arduous and expensive, but there is no time to waste.
Rajiv J. Shah

 

Foreign Policy
http://foreignpolicy.com/
Accessed 5 Jun 2021[No new, unique, relevant content]

 

New Yorker
http://www.newyorker.com/
Accessed 5 Jun 2021
Annals of Technology
The Peril of Not Vaccinating the World
Absent a concerted global commitment to vaccine equity, the virus will continue to evolve, and humanity may be consigned to a never-ending pandemic.
By Sue Halpern
June 3, 2021

 

New York Times
http://www.nytimes.com/
Accessed 5 Jun 2021
Africa
The coronavirus surges across Africa as vaccine programs flounder.
The W.H.O. said that test positivity had risen in 14 countries on the African continent over the last seven days, and that eight had reported surges of over 30 percent in new cases.
By Abdi Latif Dahir

World
India’s top court criticizes Narendra Modi’s government for a sluggish vaccination program.
By Suhasini Raj and Mujib Mashal

 

Washington Post
https://www.washingtonpost.com/
Accessed 5 Jun 2021
[No new, unique, relevant content]